-- VVT Med(VVTM.V)は、以前発表した仲介業者を介さない私募増資の第1弾を完了し、総額最大300万ドルを調達したと水曜日に発表した。同社は、1ユニットあたり0.25ドルで4,262,654ユニットを発行し、総額106万5,000ドルを調達した。 各ユニットは、普通株式1株と普通株式購入権の半分で構成され、各購入権は発行日から2年間、1株あたり0.375ドルの行使価格で普通株式1株に転換可能である。 調達資金は、米国および世界における事業拡大、予想される需要に対応するための製品製造、運転資金、および一般的な企業ニーズに充当される予定であると述べ、第2弾の私募増資も追って完了する予定であると付け加えた。 同社の株式は4月20日にトロント証券取引所ベンチャー市場で0.23ドルで取引を終えた。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.